Evaluation of Hepatitis B Vaccination with Different Dose on Blocking Mother-to-child Transmission

YAO Jun,CHEN Yong-di,LOU Bin,REN Jing-jing
DOI: https://doi.org/10.3784/j.issn.1003-9961.2010.12.016
2010-01-01
Abstract:Objective To evaluate the immunization efficacy of three doses of recombinant hepatitis B vaccine in the newborns whose mothers were HBsAg positive,and provide evidence for the development of immunization protocol.MethodsA total of 637 newborns whose mothers were HBsAg positive during pregnant or childbearing were selected from 2005 to 2007 and were divided into 3 groups to receive 5 μg,10 μg and 20 μg recombinant hepatitis B vaccine at 0,1 and 6 months respectively.Blood samples were taken from them within 1-6 months after vaccination to detect HBsAg by microparticle enzyme immunoassay(MEIA) and anti-HBs by chemiluminescence analysis.Results The HBsAg positive rate was 3.80% for 5 μg group,4.64% for 10 μg group and 2.89% for 20 μg group.The anti-HBs positive rate was 66.30%for 5 μg group,89.29% for 10 μg group and 91.33% for 20 μg group.There was no statistical differences on HBsAg positive rates among three groups(χ2=0.881,P=0.644),while the differences on anti-HBs positive rates in three groups were statistically significant(χ2=53.183,P﹤0.001) and the geometric mean concentrations(GMCs)of the anti-HBs in both 10 μg group and 20 μg group were higher than that in 5 μg group.Conclusion The efficacy of vaccination protocol of 10 μg×3 recombinant yeast derived hepatitis B vaccine and 20 μg×3 recombinant CHO hepatitis B vaccine is optimal.
What problem does this paper attempt to address?